JUL 29, 2020 10:00 AM EDT

Metabolic control of T cell tolerance and antitumor immunity

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Member (Professor), Robert G. Webster Endowed Chair, Department of Immunology, St. Jude Children's Research Hospital
    Biography
      Hongbo Chi, Ph.D. received his Ph.D. from the University of Rochester, and his postdoctoral training from Yale University School of Medicine. In 2007, he started his independent research program at St. Jude Children's Research Hospital, where he is currently a member (professor) in the Department of Immunology, and Robert G. Webster Endowed Chair in Immunology. His research focuses on mechanisms of immune signaling and metabolism, in particular how mTOR and other signaling pathways interplay with metabolic programs in T cell fate decisions. His laboratory has discovered the critical importance of mTOR signaling, metabolism and autophagy in the differentiation and function of effector and regulatory T cells, the control of T cell quiescence and antigen-triggered exit from quiescence, and the regulation of autoimmune and infectious diseases and cancer. His research has also contributed to our understanding of the signaling and metabolic pathways in dendritic cell biology and the crosstalk between innate and adaptive immunity. More recently, his laboratory applies systems biology and immunology approaches, such as proteomics, metabolomics, single cell RNA-sequencing (scRNA-Seq), CRISPR screening and integrative network analysis, to reconstruct metabolic signaling circuits and identify new therapeutic targets in cancer and other immune-mediated diseases.

    Abstract

    Coordination of immune cell metabolic programs with cell fate and state is a fundamental determinant of immune responses. Emerging evidence highlights that the interplay between immune signaling and metabolic programming orchestrates the activation and differentiation of T cells that further impact the outcome of immune responses. In particular, immunometabolism has key roles in shaping the functional fitness of both regulatory and effector T cells in the tumor microenvironment. Here I will discuss our recent findings regarding how mTOR and other signaling pathways bridge nutrient signals and cell metabolic programs to direct T cell priming and function, and the implications in immune tolerance and antitumor immunity. I will also discuss the use of systems immunology and functional genomics approaches including pooled CRISPR screening to investigate metabolic signaling and identify new therapeutic targets in cancer therapy.

     

    Learning Objectives:

    Discover how:

    1. Immunometabolism has key roles in shaping the functional fitness of both regulatory and effector T cells in the tumor microenvironment.

    2. mTOR and other signaling pathways bridge nutrient signals and cell metabolic programs to direct T cell priming and function, and the implications in immune tolerance and antitumor immunity.

    3. The use of systems immunology and functional genomics approaches including pooled CRISPR screening is powerful to explore metabolic signaling and discover new therapeutic targets in cancer therapy.


    Show Resources
    You May Also Like
    FEB 19, 2020 11:00 AM PST
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    MAR 11, 2020 6:00 AM PDT
    C.E. CREDITS
    MAR 11, 2020 6:00 AM PDT
    The locomotion of humans and other animals requires a seamless flow of information from sensory modalities all the way to the motor periphery. As such, locomotion is an excellent system for...
    APR 30, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 30, 2020 8:00 AM PDT
    DATE:April 30, 2020 TIME: 8AM PT, 11AM ET, 4PM BST, 5PM CEST Cytokinesis is the physical separation of two cells that occurs after the completion of mitosis. The mechanism underlying it is v...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    AUG 26, 2020 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    AUG 26, 2020 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: August 26, 2020 TIME: 8:00 am PDT The host immune "recognition" of cancer forms the basis of modern tumor immmunotherapy, a highly targeted treatment option with the demonstr...
    Loading Comments...
    Show Resources